Scalable Hydrogel Nanoparticle Enrichment for Enhanced Mass Spectrometry-based Proteomic Analysis of Plasma or Volumetric Dried Blood Samples

The human body is a vast, bustling city of molecules, and circulating within the blood is a complex library of proteins that tells the story of our health. These proteins act as messengers, carrying signals about aging, disease, and the body's response to injury. For scientists trying to understand conditions like Alzheimer's disease, reading this library is essential. However, the library is notoriously difficult to navigate. In a single drop of blood, a few thousand highly abundant proteins, such as those that carry oxygen or fight infection, drown out the thousands of rare, critical proteins that might hold the key to diagnosing a disease. To find these rare signals, researchers must first filter out the noise, a process that has traditionally required large amounts of blood drawn by a professional and processed in a lab. This creates a barrier for long-term studies where patients might need to provide samples frequently or from remote locations. A newer method, using small devices to collect a precise volume of blood onto a dried spot, offers a way to bypass these barriers, but it remains unclear whether the proteins in these dried samples can be analyzed with the same depth and accuracy as those in liquid blood.

A team of researchers set out to solve this problem by developing a streamlined, one-day workflow capable of extracting and analyzing proteins from both liquid plasma and these dried blood spots. Their goal was to create a method that is not only deep enough to find thousands of proteins but also precise enough to trust the numbers they generate, all while being simple enough to handle dozens of samples at once. They tested a specific technology involving tiny, specialized particles designed to grab onto proteins, effectively pulling the rare ones out of the crowd. By refining this process, they aimed to prove that the information gained from a simple, self-collected dried blood sample is just as reliable as that from a traditional hospital blood draw, opening the door to large-scale studies that were previously impossible.

The researchers began by testing two different versions of this particle-based extraction method on liquid blood plasma. They compared their approach against two other established techniques: one that uses a fully automated machine and another that relies on a simpler, non-enriched method. The automated machine performed exceptionally well, identifying nearly 7,000 proteins with high precision, while the simple non-enriched method struggled, finding far fewer proteins and producing less consistent results. The researchers' particle-based method, however, came very close to the performance of the automated machine, identifying over 6,000 proteins with a high degree of accuracy. This initial success confirmed that their manual, laboratory-built approach was a viable alternative for analyzing liquid blood.

The true test, however, lay in applying this method to the dried blood samples. When the team switched to the dried spots, they discovered that the two versions of their extraction buffer behaved in opposite ways. The buffer that worked best for liquid plasma performed poorly on the dried samples, while the other buffer, which was less effective for plasma, excelled at pulling proteins out of the dried blood. This finding highlighted a crucial difference between the two sample types: in liquid blood, proteins are already dissolved and ready to be captured, whereas in dried blood, they are trapped in a solid matrix and must be coaxed out first. By using the correct buffer for each sample type, the team was able to recover thousands of proteins from the dried spots, proving that the method could be adapted to different forms of blood collection.

To make the process fast enough for large studies, the researchers also tackled the time-consuming step of breaking the proteins down into smaller pieces for analysis. Traditionally, this digestion step takes overnight, but the team tested whether it could be done in just two hours without losing quality. They found that the shorter time produced results nearly identical to the longer process, with no significant loss in the number of proteins identified or the precision of the measurements. This breakthrough allowed them to condense the entire workflow into a single day, transforming a multi-day ordeal into a routine procedure that could be completed on a standard laboratory plate holding ninety-six samples at once.

When the team validated this new, one-day, plate-based workflow over three separate days, the results were robust. For liquid plasma, they consistently identified nearly 5,000 unique proteins, with measurements that were highly reproducible from day to day. For the dried blood samples, they identified over 3,600 proteins, with a level of consistency that, while slightly lower than plasma, was still strong enough for reliable scientific analysis. Most importantly, the proteins found in the dried blood matched those found in the liquid plasma with a high degree of agreement. About three-quarters of the shared proteins appeared in both sample types with similar abundance, suggesting that the dried blood samples provide a true and accurate reflection of the body's circulating protein landscape.

The researchers then tested whether this method could detect proteins specifically linked to Alzheimer's disease. They looked for twenty known markers associated with the condition and found that seventeen of them were detectable in at least one of the sample types. Crucially, key proteins such as apolipoprotein E, which is a major genetic risk factor for late-onset Alzheimer's, were found in both the liquid and dried samples with high precision. The method also successfully identified other proteins related to blood clotting and inflammation that were more abundant in the dried blood, likely due to the presence of red blood cells in the whole blood sample. These findings suggest that the new workflow is sensitive enough to capture biologically relevant signals, even from the challenging environment of a dried blood spot.

While the study was limited to samples from just two individuals, the results provide a strong foundation for future research. The team demonstrated that a scalable, one-day workflow can successfully enrich and analyze proteins from both liquid and dried blood with high precision. By proving that dried blood spots can yield data comparable to traditional plasma samples, this work removes a significant logistical hurdle for clinical research. It suggests that in the future, patients could potentially monitor their health or participate in large disease studies by simply collecting a small drop of blood at home, sending it in the mail, and having it analyzed with the same rigor as a hospital sample. The method offers a practical path forward for understanding the complex protein signatures of disease, making deep proteomic analysis accessible to a wider range of people and locations.